Abiopharma

Viridian Therapeutics, Inc. - Viridian Therapeutics Prepares for Transformational 2026

(75% Positive) GENPREX, INC. (GNPX) Announces Clinical Development Update

Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Prepares for Transformational 2026

Insulet - Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

(90% Positive) Apogee Therapeutics, Inc. (APGE) Announces Enrollment Update for zumilokibart Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

I-Mab (IMAB) Files Form 6-K

Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287

BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference

Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Alcoholic Beers and Hemp-Derived THC Beverages

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate

Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy